Harmony Biosciences Holdings Inc.: The Winning Streak Continues (HRMY)

March 29, 2022 09:55:46

Shares of Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) traded today at $52.07, eclipsing its 52-week high. So far today approximately 126,000 shares have been exchanged, as compared to an average 30-day volume of 456,000 shares.

Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) has potential upside of 0.1% based on a current price of $51.09 and analysts’ consensus price target of $51.16.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.

In the past 52 weeks, Harmony Biosciences Holdings Inc. share prices are bracketed by a low of $25.09 and a high of $52.07 and is now at $51.09, 104% above that low price.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About IBN (InvestorBrandNetwork)

IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer